ImmunoScience, Inc. Information

View Top Employees from ImmunoScience, Inc.

ImmunoScience, Inc. is a biotechnology research and development company specializing in the diagnosis and treatment of HIV. ImmunoScience's flagship product is Contre Vir™, a recombinant, live, attenuated therapeutic vaccine for the treatment and potential cure of AIDS and the HIV infection. Contre Vir™ has shown a very high level of success in pre-clinical studies and pilot clinical trials. Further studies are in final planning stages in several countries where interest is extremely high. ImmunoScience has several patents for Contre Vir™ across the globe and is expected to start Phase I clinical trials for Contre Vir™ in the very near future. The preliminary work for these trials is already underway in the United States, Belgium, Ghana and Uganda. ImmunoScience considers this invention to be a ground-breaking step forward in the fight against AIDS and HIV.

Website	https://www.immunoscience.com
Revenue	$7.2 million
Employees	12 (0 on RocketReach)
Founded	1994
Address	6670 Owens Dr, Pleasanton, California 94588, US
Phone	+1 925-828-1000
Technologies	JavaScript , HTML , Nginx +6 more (view full list)
Industry	Biotechnology, Commercial & Residential Construction, Construction, Science and Engineering, Therapeutic Devices
Keywords	Hiv Research, Hiv Treatment, Biotechnology Research, Vaccine Development, Immunology Research, Infectious Disease Research, Drug Development, Biopharmaceutical Research, Immunotherapy, Virology Research, Clinical Research, Pharmaceutical Research, Biotechnology
Competitors	Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Sanofi, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences +42 more (view full list)
SIC	SIC Code 152 Companies, SIC Code 15 Companies
NAICS	NAICS Code 23 Companies, NAICS Code 236 Companies